Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.

Purzner T, Purzner J, Buckstaff T, Cozza G, Gholamin S, Rusert JM, Hartl TA, Sanders J, Conley N, Ge X, Langan M, Ramaswamy V, Ellis L, Litzenburger U, Bolin S, Theruvath J, Nitta R, Qi L, Li XN, Li G, Taylor MD, Wechsler-Reya RJ, Pinna LA, Cho YJ, Fuller MT, Elias JE, Scott MP.

Sci Signal. 2018 Sep 11;11(547). pii: eaau5147. doi: 10.1126/scisignal.aau5147.

PMID:
30206138
2.

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.

Evens AM, Advani RH, Helenowski IB, Fanale M, Smith SM, Jovanovic BD, Bociek GR, Klein AK, Winter JN, Gordon LI, Hamlin PA.

J Clin Oncol. 2018 Sep 4:JCO2018790139. doi: 10.1200/JCO.2018.79.0139. [Epub ahead of print]

PMID:
30179569
3.

Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?

Gordon LI.

Lancet Haematol. 2018 Sep;5(9):e381-e382. doi: 10.1016/S2352-3026(18)30138-8. No abstract available.

PMID:
30172340
4.

In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma.

Frank MJ, Reagan PM, Bartlett NL, Gordon LI, Friedberg JW, Czerwinski DK, Long SR, Hoppe RT, Janssen R, Candia AF, Coffman RL, Levy R.

Cancer Discov. 2018 Aug 28. doi: 10.1158/2159-8290.CD-18-0743. [Epub ahead of print]

PMID:
30154192
5.

Topical vancomycin surgical prophylaxis in pediatric open craniotomies: an institutional experience.

Ho AL, Cannon JGD, Mohole J, Pendharkar AV, Sussman ES, Li G, Edwards MSB, Cheshier SH, Grant GA.

J Neurosurg Pediatr. 2018 Aug 24:1-6. doi: 10.3171/2018.5.PEDS17719. [Epub ahead of print]

PMID:
30141749
6.

Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study.

Xie L, Nagpal S, Wakelee HA, Li G, Soltys SG, Neal JW.

Oncologist. 2018 Aug 20. pii: theoncologist.2018-0264. doi: 10.1634/theoncologist.2018-0264. [Epub ahead of print]

PMID:
30126856
7.

Current overview and treatment of mantle cell lymphoma.

Schieber M, Gordon LI, Karmali R.

F1000Res. 2018 Jul 25;7. pii: F1000 Faculty Rev-1136. doi: 10.12688/f1000research.14122.1. eCollection 2018. Review.

8.

Getting to transplant in Hodgkin lymphoma: BVB.

Gordon LI.

Blood. 2018 Jul 5;132(1):1-3. doi: 10.1182/blood-2018-05-848366. No abstract available.

PMID:
29976776
9.

Multiple Extradural Spinal Meningiomas in a Patient with Acquired Immunodeficiency Syndrome: Case Report and Literature Review.

Ghanchi H, Hariri OR, Takayanagi A, Li G.

World Neurosurg. 2018 Sep;117:366-370. doi: 10.1016/j.wneu.2018.06.162. Epub 2018 Jul 20.

PMID:
29966786
10.

Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells.

Chukkapalli V, Gordon LI, Venugopal P, Borgia JA, Karmali R.

Oncotarget. 2018 Apr 20;9(30):21166-21181. doi: 10.18632/oncotarget.24989. eCollection 2018 Apr 20.

11.

First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.

Miller SE, Tummers WS, Teraphongphom N, van den Berg NS, Hasan A, Ertsey RD, Nagpal S, Recht LD, Plowey ED, Vogel H, Harsh GR, Grant GA, Li GH, Rosenthal EL.

J Neurooncol. 2018 Aug;139(1):135-143. doi: 10.1007/s11060-018-2854-0. Epub 2018 Apr 6.

12.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N.

J Natl Compr Canc Netw. 2018 Mar;16(3):245-254. doi: 10.6004/jnccn.2018.0013.

PMID:
29523663
13.

Consolidation and maintenance in follicular lymphoma: radioimmunotherapy revisited?

Gordon LI.

Lancet Haematol. 2018 Mar;5(3):e96-e97. doi: 10.1016/S2352-3026(18)30015-2. Epub 2018 Jan 26. No abstract available.

PMID:
29396095
14.

GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents.

Karmali R, Chukkapalli V, Gordon LI, Borgia JA, Ugolkov A, Mazar AP, Giles FJ.

Oncotarget. 2017 Nov 11;8(70):114924-114934. doi: 10.18632/oncotarget.22414. eCollection 2017 Dec 29.

15.

Rituximab: a benchmark in the development of chemotherapy-free treatment strategies for follicular lymphomas.

Karmali R, Kimby E, Ghielmini M, Flinn IW, Gordon LI, Zucca E.

Ann Oncol. 2018 Feb 1;29(2):332-340. doi: 10.1093/annonc/mdx768.

PMID:
29206891
16.

In Reply: The Use of Vancomycin Powder for Surgical Prophylaxis Following Craniotomy.

Ho AL, Li GH.

Neurosurgery. 2018 Feb 1;82(2):E71. doi: 10.1093/neuros/nyx537. No abstract available.

PMID:
29149292
17.

Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.

Fujimoto D, von Eyben R, Gibbs IC, Chang SD, Li G, Harsh GR, Hancock S, Fischbein N, Soltys SG.

J Neurooncol. 2018 Jan;136(1):207-212. doi: 10.1007/s11060-017-2647-x. Epub 2017 Nov 2.

PMID:
29098569
18.

Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.

Darmanis S, Sloan SA, Croote D, Mignardi M, Chernikova S, Samghababi P, Zhang Y, Neff N, Kowarsky M, Caneda C, Li G, Chang SD, Connolly ID, Li Y, Barres BA, Gephart MH, Quake SR.

Cell Rep. 2017 Oct 31;21(5):1399-1410. doi: 10.1016/j.celrep.2017.10.030.

19.

Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors.

Allen PB, Gordon LI.

Clin Med Insights Oncol. 2017 Sep 26;11:1179554917731072. doi: 10.1177/1179554917731072. eCollection 2017. Review.

20.

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS.

Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.

PMID:
28985567
21.

Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin.

Rink JS, Yang S, Cen O, Taxter T, McMahon KM, Misener S, Behdad A, Longnecker R, Gordon LI, Thaxton CS.

Mol Pharm. 2017 Nov 6;14(11):4042-4051. doi: 10.1021/acs.molpharmaceut.7b00710. Epub 2017 Oct 3.

PMID:
28933554
22.

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.

Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM.

Cancer. 2018 Jan 1;124(1):136-144. doi: 10.1002/cncr.30979. Epub 2017 Sep 13.

PMID:
28902390
23.

Comparison of Porcine and Bovine Collagen Dural Substitutes in Posterior Fossa Decompression for Chiari I Malformation in Adults.

Lee CK, Mokhtari T, Connolly ID, Li G, Shuer LM, Chang SD, Steinberg GK, Hayden Gephart M.

World Neurosurg. 2017 Dec;108:33-40. doi: 10.1016/j.wneu.2017.08.061. Epub 2017 Aug 31.

PMID:
28838875
24.

Endoscopic vs. Microscopic Resection of Sellar Lesions-A Matched Analysis of Clinical and Socioeconomic Outcomes.

Azad TD, Lee YJ, Vail D, Veeravagu A, Hwang PH, Ratliff JK, Li G.

Front Surg. 2017 Jun 22;4:33. doi: 10.3389/fsurg.2017.00033. eCollection 2017.

25.

Microsurgical vs. Endoscopic Excision of Colloid Cysts: An Analysis of Complications and Costs Using a Longitudinal Administrative Database.

Connolly ID, Johnson E, Lamsam L, Veeravagu A, Ratliff J, Li G.

Front Neurol. 2017 Jun 9;8:259. doi: 10.3389/fneur.2017.00259. eCollection 2017.

26.

Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma.

Shah JL, Li G, Shaffer JL, Azoulay MI, Gibbs IC, Nagpal S, Soltys SG.

Neurosurgery. 2018 Jan 1;82(1):24-34. doi: 10.1093/neuros/nyx115. Review.

PMID:
28605463
27.

Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.

Pollom EL, Fujimoto D, Wynne J, Seiger K, Modlin LA, Jacobs LR, Azoulay M, von Eyben R, Tupper L, Gibbs IC, Hancock SL, Li G, Chang SD, Adler JR, Harsh GR, Harraher C, Nagpal S, Thomas RP, Recht LD, Choi CYH, Soltys SG.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):123-130. doi: 10.1016/j.ijrobp.2017.01.242. Epub 2017 Feb 7.

PMID:
28586949
28.

History and current state of immunotherapy in glioma and brain metastasis.

McGranahan T, Li G, Nagpal S.

Ther Adv Med Oncol. 2017 May;9(5):347-368. doi: 10.1177/1758834017693750. Epub 2017 Feb 1. Review.

29.

Strategies for Management of Relapsed or Refractory Hodgkin Lymphoma.

Gordon LI.

J Natl Compr Canc Netw. 2017 May;15(5S):716-718.

PMID:
28515253
30.

Neurosurgery concepts: Key perspectives on endoscopic versus microscopic resection for pituitary adenomas, surgical decision-making in tuberculum sellae meningiomas, optic nerve mobilization during resection of craniopharyngiomas, and evaluation of headache and quality of life after endoscopic transphenoidal surgery for pituitary adenomas.

Germanwala AV, Hofler R, Lagman C, Chung LK, Khalessi AA, Zada G, Smith ZA, Dahdaleh NS, Bohnen AM, Cho JM, Colen CB, Duckworth E, Kan P, Lam S, Kim CY, Li G, Lim M, Sherman JH, Wang VY, Yang I.

Surg Neurol Int. 2017 Apr 5;8:52. doi: 10.4103/sni.sni_17_17. eCollection 2017. No abstract available.

31.

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Smith M, Winter JN, Yahalom J, Burns J, Ogba N, Sundar H.

J Natl Compr Canc Netw. 2017 May;15(5):608-638.

PMID:
28476741
32.

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.

Galanina N, Smith SM, Liao C, Petrich A, Libao B, Gartenhaus R, Westin JR, Cohen KS, Knost JA, Stadler WM, Doyle A, Karrison T, Gordon LI, Evens AM.

Br J Haematol. 2018 Apr;181(2):264-267. doi: 10.1111/bjh.14544. Epub 2017 Apr 17. No abstract available.

33.

Impact of cachexia on outcomes in aggressive lymphomas.

Karmali R, Alrifai T, Fughhi IAM, Ng R, Chukkapalli V, Shah P, Basu S, Nathan S, Szymanski-Grant K, Gordon LI, Venugopal P, Penedo FJ, Borgia JA.

Ann Hematol. 2017 Jun;96(6):951-956. doi: 10.1007/s00277-017-2958-1. Epub 2017 Apr 17.

PMID:
28417157
34.

Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity.

Regan JA, Cao Y, Dispenza MC, Ma S, Gordon LI, Petrich AM, Bochner BS.

J Allergy Clin Immunol. 2017 Sep;140(3):875-879.e1. doi: 10.1016/j.jaci.2017.03.013. Epub 2017 Apr 4. No abstract available.

PMID:
28389390
35.

The Use of Vancomycin Powder for Surgical Prophylaxis Following Craniotomy.

Ravikumar V, Ho AL, Pendhakar AV, Sussman ES, Kwong-Hon Chow K, Li G.

Neurosurgery. 2017 May 1;80(5):754-758. doi: 10.1093/neuros/nyw127.

PMID:
28327930
36.

Cranioplasty Complications and Costs: A National Population-Level Analysis Using the MarketScan Longitudinal Database.

Li A, Azad TD, Veeravagu A, Bhatti I, Long C, Ratliff JK, Li G.

World Neurosurg. 2017 Jun;102:209-220. doi: 10.1016/j.wneu.2017.03.022. Epub 2017 Mar 16.

PMID:
28315803
37.

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

Wierda WG, Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Caimi P, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Harris NL, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Martin MG, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Snyder ED, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2017 Mar;15(3):293-311.

PMID:
28275031
38.

Molecular Subtyping in Diffuse Large B Cell Lymphoma: Closer to an Approach of Precision Therapy.

Karmali R, Gordon LI.

Curr Treat Options Oncol. 2017 Feb;18(2):11. doi: 10.1007/s11864-017-0449-1. Review.

PMID:
28229364
39.

Neurosurgery concepts: Key perspectives on imaging characteristics of spinal metastases, surgery for low back pain, anesthesia for disc surgery, and laminectomy versus laminectomy and fusion for lumbar spondylolisthesis.

Lagman C, Chung LK, Macyszyn L, Choy W, Smith ZA, Dahdaleh NS, Bohnen AM, Cho JM, Colen CB, Duckworth E, Germanwala AV, Kan P, Khalessi AA, Kim CY, Lam S, Li G, Lim M, Sherman JH, Wang VY, Zada G, Yang I.

Surg Neurol Int. 2017 Jan 19;8:9. doi: 10.4103/2152-7806.198736. eCollection 2017. No abstract available.

40.

Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.

Karmali R, Nabhan C, Petrich AM, Raizer J, Peace D, Lukas R, Gordon LI, Basu S, Chukkapalli V, Venugopal P.

Br J Haematol. 2017 Apr;177(1):72-79. doi: 10.1111/bjh.14522. Epub 2017 Feb 17.

PMID:
28211579
41.

Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop.

Kahl BS, Dreyling M, Gordon LI, Quintanilla-Martinez L, Sotomayor EM.

Leuk Lymphoma. 2017 Jul;58(7):1561-1569. doi: 10.1080/10428194.2017.1283036. Epub 2017 Jan 31.

PMID:
28140709
42.

Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery.

Iyer A, Halpern CH, Grant GA, Deb S, Li GH.

Cureus. 2016 Dec 7;8(12):e919. doi: 10.7759/cureus.919.

43.

Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia.

McMahon KM, Scielzo C, Angeloni NL, Deiss-Yehiely E, Scarfo L, Ranghetti P, Ma S, Kaplan J, Barbaglio F, Gordon LI, Giles FJ, Thaxton CS, Ghia P.

Oncotarget. 2017 Feb 14;8(7):11219-11227. doi: 10.18632/oncotarget.14494.

44.

Recommendations for Clinical Trial Development in Follicular Lymphoma.

Maddocks K, Barr PM, Cheson BD, Little RF, Baizer L, Kahl BS, Leonard JP, Fowler N, Gordon LI, Link BK, Friedberg JW, Ansell SM.

J Natl Cancer Inst. 2016 Dec 31;109(3). doi: 10.1093/jnci/djw255. Print 2017 Mar. Review.

45.
46.

The impact of fertility preservation on treatment delay and progression-free survival in women with lymphoma: a single-centre experience.

Allen PB, Pavone ME, Smith KN, Kazer RR, Rademaker A, Lawson AK, Moravek MB, Confino R, Gordon LI, Winter JN.

Br J Haematol. 2018 Mar;180(6):901-904. doi: 10.1111/bjh.14466. Epub 2016 Dec 16. No abstract available.

48.

Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499.

Smith MR, Hong F, Li H, Gordon LI, Gascoyne RD, Paietta EM, Advani RH, Forero-Torres A, Horning SJ, Kahl BS.

Leukemia. 2017 Feb;31(2):517-519. doi: 10.1038/leu.2016.305. Epub 2016 Oct 26. No abstract available.

49.

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

Zhou Z, Rademaker AW, Gordon LI, LaCasce AS, Crosby-Thompson A, Vanderplas A, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson MM, Zelenetz AD, Niland J, Friedberg JW, Winter JN.

J Natl Compr Canc Netw. 2016 Oct;14(10):1274-1281.

50.

PD-1 blockade in Hodgkin's lymphoma: learning new tricks from an old teacher.

Allen PB, Gordon LI.

Expert Rev Hematol. 2016 Oct;9(10):939-49. doi: 10.1080/17474086.2016.1235970. Epub 2016 Sep 23. Review.

PMID:
27622603

Supplemental Content

Loading ...
Support Center